Combined blood markers correctly detect early pancreatic cancer in human cancer cells
A newly identified biomarker panel could pave the way to earlier detection and better treatment for pancreatic cancer, according to new research from the Perelman School of Medicine at University of Pennsylvania. Currently over 53,000 people in the United States are diagnosed with pancreatic cancer — the fourth leading cause of cancer death — every year. The blood biomarkers, detailed today in Science Translational Medicine, correctly detected pancreatic cancer in blood samples from patients at different stages of their disease.
The majority of pancreatic cancer patients are not diagnosed until an advanced stage, beyond the point at which their tumors can be surgically removed.
A team led by Ken Zaret, PhD, director of the Penn Institute for Regenerative Medicine and the Joseph Leidy Professor of Cell and Developmental Biology, and Gloria Petersen, PhD, from the Mayo Clinic, identified a pair of biomarkers that physicians could soon use to discover the disease earlier.
“Starting with our cell model that mimics human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this cancer,” Zaret said. The authors anticipate that health care providers will use the early-detection biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals with a high risk of developing pancreatic cancer, including those who have a first-degree relative with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.
“Early detection of cancer has had a critical influence on lessening the impact of many types of cancer, including breast, colon, and cervical cancer. A long standing concern has been that patients with pancreatic cancer are often not diagnosed until it is too late for the best chance at effective treatment,” said Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center (ACC) at the University of Pennsylvania. “Having a biomarker test for this disease could dramatically alter the outlook for these patients.”
Novel method for discovering pancreatic cancer biomarkers
Credit: The lab of Ken Zaret, Perelman School of Medicine, University of Pennsylvania
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret’s lab, builds on a first-of-its-kind human-cell model of pancreatic cancer progression the lab described in 2013. They used stem-cell technology to create a cell line from a patient with advanced pancreatic ductal adenocarcinoma. Genetically reprogramming late-stage human cancer cells to a stem-cell state enabled them to force the reprogrammed cells to progress to an early cancerous state, revealing secreted blood biomarkers of early-stage disease along the way.
The best candidate biomarker, plasma thrombospondin-2 (THBS2), was screened against 746 cancer and control plasma samples using an inexpensive, commercially available protein-detection assay. The team found that blood levels of THBS2, combined with levels of a known later-stage biomarker called CA19-9, was reliable at detecting the presence of pancreatic cancer in patients.
The team refined the assay with independent investigations of plasma samples from patients with different stages of cancer, from individuals with benign pancreatic disease, and from healthy controls, all obtained from Petersen, who directs the biospecimen resource program for pancreas research at the Mayo Clinic.
“Positive results for THBS2 or CA19-9 concentrations in the blood consistently and correctly identified all stages of the cancer,” Zaret said. “Notably, THBS2 concentrations combined with CA19-9 identified early stages better than any other known method.” The combination panel also improved the ability to distinguish cases of cancer from pancreatitis. The panel will next be validated in a set of samples from pancreatic cancer patients who provided a research blood sample prior to their diagnosis.
The Latest on: Pancreatic cancer
[google_news title=”” keyword=”pancreatic cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- BioLineRx doses first subject in Phase II pancreatic cancer trialon February 29, 2024 at 10:41 am
BioLineRx has dosed the first subject in the Phase II CheMo4METPANC clinical trial evaluating the CXCR4 inhibitor motixafortide for the treatment of first-line pancreatic cancer (PDAC). The trial aims ...
- Groundbreaking New Blood Test Offers Early Pancreatic Cancer Diagnosis Study Sayson February 29, 2024 at 10:32 am
As reported in today's issue of the journal Metabolites, researchers at Metabolomycs, a California-based biotechnology company, for the first time applied targeted mass spectrometry to show that ...
- Pancreatic cancer survival rates improving, but doctors warn it's still tough to spoton February 29, 2024 at 8:53 am
Survival rates for pancreatic cancer are up, but doctors caution there's still more work to be done. Pancreatic cancer is the 10th most commonly diagnosed cancer. It's predicted that more than 66,000 ...
- Babbo’s Italian Eatery holding ‘day of giving’ to fund pancreatic cancer researchon February 29, 2024 at 7:52 am
On Thursday, customers can head over to Babbo’s Italian Eatery for “Baseball for Babbo Day,” where 100% of proceeds go toward cancer research. All of the profits are going to The Seena Magowitz ...
- Scientists discover mucus allows young pancreatic cancer cells to grow but may also prevent a deadly transformationon February 28, 2024 at 1:48 pm
Knowing exactly what's inside a tumor can maximize our ability to fight cancer. But that knowledge doesn't come easy. Tumors are clusters of constantly changing cancer cells. Some become common cancer ...
- Stacy Wakefield, wife of late former Red Sox pitcher Tim Wakefield, dies of pancreatic canceron February 28, 2024 at 1:16 pm
Stacy Wakefield, the wife of former Boston Red Sox pitcher Tim Wakefield, died Wednesday of pancreatic cancer, the Red Sox announced. “It is with deep sadness that we share that our beloved mother, ...
- What you need to know about pancreatic canceron February 28, 2024 at 12:03 pm
Pancreatic cancer is called a “silent killer” because it is usually not found until it has spread from the pancreas, making it extremely difficult to treat. Pancreatic cancer, like other cancers, ...
- Researchers looking for patients to participate in pancreatic cancer vaccine trialon February 28, 2024 at 11:02 am
This trial is testing a vaccine to treat pancreatic cancer. Researchers said it could have a huge impact in pancreatic cancer which is often not discovered until later stages. The study is designed ...
- Ask the doctors: Researchers use AI to detect pancreatic cancer sooneron February 26, 2024 at 4:00 pm
Dear Doctors: A dear friend was diagnosed with pancreatic cancer. It was so advanced, he died just a month later. I recently saw a discussion on television about using AI to detect it early, while it ...
- Increase in women being diagnosed with pancreatic canceron February 26, 2024 at 7:53 am
New statistics reveal an increase in cases of pancreatic cancer being diagnosed in women. The figures, released by Cancer Research UK (CRUK), came from comparing incidences of pancreatic cancer in the ...
via Google News and Bing News